Would be an ideal time for private equity to stitch up a deal here. The risk is loss of future contracts due to the recent scandal. A buyout and restructure wipes the slate.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025